Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
AI industry sees prosperous future in China 2024-06-04 21:13
Huawei Game Salon 2024: AppGallery bridges the gap between East and West to help partners go global 2024-06-04 19:18
Angel Yeast Partners with BakeMark Launching Multiple Product Lines at Bakery China 2024 2024-06-04 19:00
Ping An CIO Benjamin Deng: Maintaining a "Double Barbell" Asset Allocation Strategy, Seeing Potential in Investment Opportunities Brought by Energy Transition 2024-06-04 17:16
COP28 Presidency calls for global effort to leverage the rise of AI, the energy transition and the growth of the Global South to accelerate sustainable development for all 2024-06-04 16:53
Intersolar Europe 2024: Discover Hiconics' Innovative Residential Green Energy ODM Solution 2024-06-04 16:29
SANY Leads Industry's Low-Carbon Development with Market Volume of Over US$400 Million 2024-06-04 13:07
TECNO showcases its AIoT ecosystem with Multiple forms PC at COMPUTEX 2024 Centering on "Smart of Creation" 2024-06-04 12:01
RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88 2024-06-04 09:38
YCYW Held Seminar on the Trailblazing Journey of ECE Practice 2024-06-03 17:45
Trinasolar Releases Sustainability Report for 2023, Detailing its Commitment, Action and Achievements Towards a More Sustainable World 2024-06-03 17:43
First Park Hyatt hotel in central China opens in the vibrant city of Changsha 2024-06-03 14:45
Shandong Liaocheng Power Supply Company of State Grid: "Family-Like Service" Empowers the Preservation of Intangible Cultural Heritage 2024-06-03 13:45
GOODYEAR'S HOPE SHINES BRIGHT: EMPOWERING FUTURES IN TIEXI 2024-06-03 12:08
Alphamab Oncology Presented Chinese Clinical Data of Anti-HER2 Bispecific ADC JSKN003 for the First Time at the 2024 ASCO Annual Meeting 2024-06-03 10:17
Inspur Group Making Its Debut at the 2024 Asia Tech x Singapore (ATxSG) 2024-06-03 10:03
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatment of Colon Cancer at 2024 ASCO Annual Meeting 2024-06-03 09:44
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer and Gastric Cancer 2024-06-03 09:35
Innovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting 2024-06-02 13:19
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC 2024-06-02 08:24
1 94 95 96 97 98 1243